Quality of Life in Prostate Cancer Patients After Different Treatments
Author Information
Author(s): Joseph Kurian Jones, Alvi Riaz, Skarsgard David, Tonita Jon, Pervez Nadeem, Small Cormac, Tai Patricia
Primary Institution: Cross Cancer Institute & University of Alberta
Hypothesis
Does the combination of external beam radiotherapy and high dose rate brachytherapy provide better health-related quality of life compared to external beam radiotherapy alone in prostate cancer patients one year after treatment?
Conclusion
There was no significant difference in quality of life scores between prostate cancer patients treated with EBRT alone and those treated with combined EBRT and HDRBT one year after treatment.
Supporting Evidence
- The study included 111 patients who completed a quality of life survey one year after treatment.
- No significant differences were found in quality of life scores between the two treatment groups.
- The study highlights the importance of HRQoL in treatment decision-making for prostate cancer.
Takeaway
This study looked at how happy and healthy prostate cancer patients felt after two different treatments, and found that both groups felt about the same one year later.
Methodology
Patients completed a quality of life survey one year after treatment, comparing those who received EBRT alone to those who received EBRT and HDRBT.
Potential Biases
Potential bias due to non-randomized design and single-institution setting.
Limitations
The study is a single-institutional non-randomized study with a small sample size in the EBRT plus HDRBT arm and lacks baseline HRQoL information.
Participant Demographics
Median age of participants was 69 years, with a range of 46 to 84 years.
Statistical Information
P-Value
0.668
Statistical Significance
p = 0.668
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website